GregoryLeeAllersDO

Family Medicine • Portland, OR

Physician

Join to view full profile

Are you Dr. Allers?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 35 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
426 SW Stark St
# 8
Portland, OR 97204
Phone+1 503-988-3674

Fax+1 503-988-5180
Is this information wrong?

Summary

Dr. Gregory Allers, DO is a board certified family physician in Portland, Oregon. He is currently licensed to practice medicine in Oregon and Michigan.

Education & Training

Oregon Health & Science UniversityResidency, Family Medicine, 1986 - 1988
Garden City HospitalInternship, Transitional Year, 1984 - 1985
Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 1984

Certifications & Licensure

OR State License 1986 - 2024
MI State License 1984 - 1985
American Board of Family Medicine Family Medicine

Publications & Presentations

PubMed

Relationship between regional distribution of imipramine and its effect on learned helplessness in the rat.
Sherman, A. D., Allers, G. L.> ;Neuropharmacology. 1980 Feb
Effect of selective midbrain and diencephalic 5,7-dihydroxytryptamine lesions on serotonin content in individual preopticohypothalamic nuclei and on serum luteinizing ...
van de Kar, L. D., Lorens, S. A., Vodraska, A., Allers, G., Green, M., Van Orden, D. E., Van Orden, L. S.> ;Neuroendocrinology. 1980 Nov
[Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author''s transl)].
Vandel, B., Vandel, S., Jounet, J. M., Allers, G., Volmat, R.> ;Encephale. 1981
[Comparative evolution of prolactin plasma levels during antidepressant treatment (author''s transl)].
Vandel, B., Vandel, S., Allers, G., Grappe, F., Volmat, R.> ;Therapie. 1981 Jan 01
Clinical pharmacology of viloxazine hydrochloride.
Vandel, B., Vandel, S., Allers, G., Volmat, R.> ;Pharmacopsychiatria. 1981 Mar
Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites.
Vandel, B., Sandoz, M., Vandel, S., Allers, G., Volmat, R.> ;Eur J Clin Pharmacol. 1982
Relationship between the plasma concentration of clomipramine and desmethylclomipramine in depressive patients and the clinical response.
Vandel, B., Vandel, S., Jounet, J. M., Allers, G., Volmat, R.> ;Eur J Clin Pharmacol. 1982
Biotransformation of amitriptyline in alcoholic depressive patients.
Sandoz, M., Vandel, S., Vandel, B., Bonin, B., Allers, G., Volmat, R.> ;Eur J Clin Pharmacol. 1983
Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
Vandel, S., Bertschy, G., Jounet, J. M., Allers, G.> ;Ther Drug Monit. 1988
[Dexamethasone test: suppressors and non-suppressors, what''s the difference?].
Vandel, S., Bonin, B., Vandel, B., Allers, G., Volmat, R.> ;Encephale. 1985 Jul 01
[Pharmacokinetic interaction between clomipramine and phenothiazines].
Vandel, S., Sandoz, M., Vandel, B., Bertschy, G., Allers, G., Volmat, R.> ;Therapie. 1987 Jan 01
Biotransformation of amitriptyline in man: interaction with phenothiazines.
Vandel, S., Sandoz, M., Vandel, B., Bonin, B., Allers, G., Volmat, R.> ;Neuropsychobiology. 1986
[Plasma desipramine levels and clinical response in patients with major depression. Results in agreement with a curvilinear relationship].
Bertschy, G., Vandel, S., Vandel, B., Allers, G., Bechtel, P.> ;Therapie. 1989 Sep 01
Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity.
Bertschy, G., Vandel, S., Vandel, B., Allers, G., Bechtel, P., Volmat, R.> ;Pharmacopsychiatry. 1989 Jul
Amitriptyline: linear or nonlinear kinetics in every day practice?
Vandel, S., Bertschy, G., Vandel, B., Allers, G., Volmat, R.> ;Eur J Clin Pharmacol. 1989
Cardiac beta-adrenergic sensitivity in depression: relation with endogenous subtype and desipramine response.
Bertschy, G., Vandel, S., Puech, A., Vandel, B., Sandoz, M., Allers, G.> ;Neuropsychobiology. 1989
[The ultrasensitive thyrotropin assay and thyroliberin test in patients with major depression].
Bertschy, G., Vandel, S., Allers, G., Volmat, R.> ;Presse Med. 1989 Oct 14
Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
Vandel, S., Vandel, B., Bonin, B., Camejo, Z., Sandoz, M., Allers, G., Volmat, R.> ;Pharmacopsychiatry. 1985 Nov
[Compliance, subdosage and overdosage of antidepressive agents in the first prescription in a hospital milieu].
Vandel, S., Bertschy, G., Vandel, B., Allers, G., Volmat, R.> ;Therapie. 1990 Mar 01
[The mode of induction of amineptine dependence. 8 cases].
Vandel, S., Bertschy, G., Bízouard, P., Luxembourger, I., Allers, G., Volmat, R.> ;Therapie. 1990 Jan 01
Nonlinear kinetics of nortriptyline in every day practice.
Vandel, S., Bertschy, G., Vandel, B., Allers, G., Volmat, R.> ;Eur J Clin Pharmacol. 1990
[Amineptin dependence. Detection of patients at risk. Report of 8 cases].
Bertschy, G., Luxembourger, I., Bizouard, P., Vandel, S., Allers, G., Volmat, R.> ;Encephale. 1990 Sep 01
Desipramine induces cardiac beta-adrenergic sensitivity decrease in major depressed patients without relationship to therapeutic response.
Bertschy, G., Vandel, S., Puech, A., Blum, D., Vandel, B., Allers, G.> ;Pharmacopsychiatry. 1990 Nov
[Valpromide-amitriptyline interaction. Increase in the bioavailability of amitriptyline and nortriptyline caused by valpromide].
Bertschy, G., Vandel, S., Jounet, J. M., Allers, G.> ;Encephale. 1990 Jan 01
Fluvoxamine-tricyclic antidepressant interaction. An accidental finding.
Bertschy, G., Vandel, S., Vandel, B., Allers, G., Volmat, R.> ;Eur J Clin Pharmacol. 1991
Join now to see all